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a b s t r a c t
Induced pluripotent stem cells (iPSCs) provide invaluable opportunities for future cell therapies as well as
for studying human development, modelling diseases and discovering therapeutics. In order to realise the
potential of iPSCs, it is crucial to comprehensively characterise cells generated from large cohorts of
healthy and diseased individuals. The human iPSC initiative (HipSci) is assessing a large panel of cell lines
to define cell phenotypes, dissect inter- and intra-line and donor variability and identify its key determi-
nant components. Here we report the establishment of a high-content platform for phenotypic analysis of
human iPSC lines. In the described assay, cells are dissociated and seeded as single cells onto 96-well
plates coated with fibronectin at three different concentrations. This method allows assessment of cell
number, proliferation, morphology and intercellular adhesion. Altogether, our strategy delivers robust
quantification of phenotypic diversity within complex cell populations facilitating future identification
of the genetic, biological and technical determinants of variance. Approaches such as the one described
can be used to benchmark iPSCs from multiple donors and create novel platforms that can readily be
tailored for disease modelling and drug discovery.
 2016 The Authors. Published by Elsevier Inc. This is an openaccess article under the CCBY license (http://
creativecommons.org/licenses/by/4.0/).
1. Introduction
Human induced pluripotent stem cells (iPSCs) offer tremendous
potential not only for cell therapy but also to develop platforms for
medical research. In particular, patient-derived iPSCs can be used
to obtain selected differentiated cell types to model diseases and
discover new therapeutics [1]. Heterogeneity in gene expression
has been described within a specific iPSC line [2], between differ-
ent donors [3,4] and through the reprogramming process [5,6].
Furthermore, several studies have focused on the differences
between a small number of lines from patients and controls or
used isogenic lines [7]. However, despite recent examples in this
direction [8] dissecting the phenotypic heterogeneity within one
cell line and among lines derived from the same donor or diverse
individuals is yet to be fully explored.
Nonetheless, a clear definition of the genetic and epigenetic
variance and how each of these affects cell behaviour in large pan-
els of iPSCs is crucial for stem cell biology. Moreover, assessing the
phenotypic variance observed in cell populations from multiple
donors will facilitate scaling up culture systems as well as the
development of quality control and automation protocols with
undoubted value for the maintenance of pluripotent stem cells
and controlled differentiation towards specific cell types.
The human induced pluripotent stem cells initiative (HipSci) is
generating iPSCs from hundreds of healthy individuals as well as
patients diagnosed with selected diseases. This represents a pow-
erful resource to evaluate and quantify cell responses to chemical,
physical and biological stimuli using novel assays and artificial
microenvironments. Within this framework, phenotypic data are
being collated with genomics, epigenomics and proteomics data
to discover the impact of their variation on the cellular phenotype.
Here we describe the development of a simple assay (including
methods, workflow and set-up) to capture and quantify phenotypic
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features of iPSCs exposed to different extracellular matrix
conditions.
2. Material and methods
2.1. iPSC quality control and maintenance
iPSCs are received from the Wellcome Trust Sanger Institute.
There, cells are reprogrammed from fibroblasts using the Sendai
virus method [9]. After reprogramming, each clone is genotyped
and tested for copy number variations (CNVs). Pluripotency is
assessed based on expression profiling [10], detection of pluripo-
tency markers in culture and response to differentiation inducing
conditions [11]. Data reported in this study refers to multiple repli-
cate experiments of a single cell line [12] (Table 1, first line). iPSCs
are passaged on Mitomycin-C inactivated mouse embryonic
fibroblasts (MEFs) in Advanced DMEM/Ham’s F-12 supplemented
with 20% v/v KnockOut Serum Replacement (all Life Technologies),
1% v/v L-Glutamine, 1% v/v Penicillin–Streptomycin (all Sigma–
Aldrich), 55 mM 2-Mercaptoethanol (Life Technologies) and 4 ng/
mL human bFGF (Millipore). Cells are split every 3–4 days using
enzymatic and mechanical dissociation and media changed daily.
Briefly, cells are washed with Dulbecco’s Phosphate Buffered Saline
(DPBS, Sigma–Aldrich) and incubated with dispase and collagenase
(all Life Technologies) for 10 min at 37 C. The enzyme solution is
then replaced with fresh culture medium and pluripotent colonies
are dissected manually. Colonies are selected based on morpholog-
ical features typical of human pluripotent stem cells and are split
approximately 1:3 onto a new feeder plate.
CF-1 MEFs (Amsbio) are cultured in Advanced Dulbecco’s
Modified Eagle Medium (DMEM)/Ham’s F-12 supplemented with
10% v/v Foetal Bovine Serum (all Life Technologies), 1% v/v
L-Glutamine and 1% v/v Penicillin–Streptomycin (all Sigma–
Aldrich). For iPSCs maintenance, inactivated MEFs are seeded as
feeders on a 6-well microplate (Falcon) coated with 0.1% gelatin
from porcine skin type A (Sigma–Aldrich) at a density of 106 cells
per 6-well plate and allowed to attach overnight.
2.2. Extracellular matrix coating conditions
To develop our assay, we first sought to identify favourable
extracellular matrix substrates. We screened and examined a total
of 74 diverse conditions from two sources (see Table 1). A
customised array plate acquired from Orla protein technologies
(Sarstedt cat. No. 02XECM-96) contained 9 conditions derived from
single ECM proteins including fibronectin, laminin, collagen,
vitronectin, osteopontin, tenascin C and bone sialoprotein and 17
conditions presented as a mixture of different ECMs. For this set,
triplicates of a single concentration of approximately 25 lg/ml
per condition were coated on wells. Additionally, we created an
array plate containing in duplicate fragments of fibrillin-1,
fibrillin-2 and agrin as well as cellular and plasma fibronectin at
a range of 1, 10 and 25 lg/ml. The plate also contained single con-
centrations of the following ECM proteins: LTBP-1 C-terminal frag-
ment, MAGP-1, syndecan-2 extracellular domain, syndecan-4
extracellular domain and fibulin 4. Extracellular matrix proteins
diluted in 80 ll PBS were incubated overnight on 96 well lClear
black tissue culture plates (Greiner cat. No. 655090) at 4 C. The
supernatant was removed and well-coating blocked by the addi-
tion of 10 mg/ml BSA for 1 h. Upon removal of the BSA solution,
the plates were stored at 80 C prior to use. Bovine Serum Albu-
min (BSA) and uncoated tissue culture plastic (TCP) were used as
controls.
For the fibronectin assay, 96-well lClear plates (Greiner) are
coated with 1, 5 and 25 lg/ml human plasma fibronectin (Corning)
and stored at 4 C (overnight or up to 14 days). We will refer to
these conditions as Fn1, Fn5 and Fn25, respectively (whereas
Fn10 was only used in the screening). Each is present in a technical
triplicate on the same vessel randomised per column using diverse
patterns (i.e. Fn1-Fn5-Fn25, Fn1-Fn25-Fn5, Fn5-Fn25-Fn1, Fn5-
Fn1-Fn25, Fn25-Fn1-Fn5, Fn25-Fn5-Fn1). Border wells are avoided
to reduce edge effects. Before use, fibronectin is removed and wells
are washed with DPBS (Sigma–Aldrich).
2.3. Assay set-up: cell seeding, fixation, staining and image acquisition
When iPSCs cultures reach approximately 80% confluency, cells
are washed with DPBS and dissociated with collagenase and dis-
pase for 45 min at 37 C. Pluripotent colonies detach from the
microplate surface and are further dissociated with Accutase
(Innovative Cell Technologies) for 5 min at 37 C. The single-cell
suspension is centrifuged for 3 min at 400 rpm after which the
supernatant is removed and cells re-suspended in fresh culture
medium (Section 2.1) supplemented with 10 lM Y-27632 Rho-
associated protein kinase (ROCK) inhibitor (Enzo Life Sciences).
Cells are then counted using a Scepter 2.0 automated cell-
counting device (Millipore) and seeded onto the fibronectin-
coated 96-well plate using Viaflo (INTEGRA Biosciences) electronic
pipettes.
At 23.5 h after seeding cells are labelled with EdU (Click-iT EdU
kit, Life Technologies) for 30 min. For fixation, 8% paraformalde-
hyde (PFA, Sigma–Aldrich) is added to an equal volume of medium
for a final concentration of 4%, and left at room temperature for
15 min. After fixation, cells are washed with DPBS (Sigma–Aldrich)
and stored at 4 C. Cells are then blocked and permeabilised with
0.1% v/v Triton X-100 (Sigma–Aldrich), 1% w/v bovine serum albu-
min (BSA, Sigma–Aldrich) and 3% v/v donkey serum (Sigma–
Aldrich) for 20 min at room temperature. After washing with DPBS,
cells are stained with Click-iT EdU kit (Life Technologies) according
to the manufacturer’s instructions except the azidofluoride reac-
tion buffer halved in DPBS. After 1 h cells are washed with DPBS,
stained for 1 h at room temperature with CellMask plasma mem-
brane stain (1:1000, Life Technologies) and DAPI nuclear stain
(1:5000, 1 lg/ml final concentration, Life Technologies). Plates
are then washed with DPBS and stored at 4 C. EdU was used
according to manufacturer’s instructions except for the concentra-
tion of the azide reagent halved. A period of half hour was chosen
in line with the cell cycle period described in the literature for
human iPSCs [6]. As a control, cells were exposed to the same
reagents in the absence of EdU incorporation showed comparable
background intensity values to the cells considered EdU negative
by our analysis. Acquisition parameters and image analysis pipe-
line are described in details in Section 3.1 and Section 3.3 respec-
tively. For endpoint analysis, stained plates are imaged using an
Operetta (Perkin Elmer) high content device. Images are acquired
in wide field mode using 4 channels (DAPI, 488, 647, Brightfield as
control). On Greiner lClear plates, we optimised heights focal set-
tings for brightfield, DAPI, EdU and CellMask (respectively 11, 20, 9
and 10 lm) following the sharpest focal plan guided by the highest
intensity of signal. Times of exposure (respectively 100, 200, 300
and 10 millisecs) were chosen to minimise the time of acquisition
and the amount of reagents used. Incucyte (Essen Bioscience)
images were acquired largely as described in [13].
3. Results and discussion
We first aimed to obtain a robust read out to evaluate response
of undifferentiated iPSCs to controlled changes in the microenvi-
ronment. Furthermore, we aimed to develop a set of procedures
to effectively extract from images relevant phenotypic features,
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Fig. 1. A screen of 74 conditions to visualise single iPS cells. List of tested substrate conditions from two combined arrays (Orla and custom made). Columns indicate an
arbitrary reference number, name concentration, motifs or residues and source are detailed. Yield refers to number of single cells observed by visual inspection indicative of
assay quality. The insets show examples of suboptimal substrates for iPSCs. Very few cells attach when plated on laminin a1 IKVAV (Table 1, n. 11, representative of conditions
1–48) and many clumps and very few single cells are observed when cells are plated on vitronectin PQVTRGDVFTM (Table 1, n. 49, representative of conditions 49–64).
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which can be quantified and interrogated in downstream phases of
the analysis. As a proof of principle for this protocol, we used here
dissociated iPSCs from a single control line in undifferentiated
culture conditions. This study serves as a foundation to build phe-
notypic signatures of large panels of iPSC lines from multiple
donors which can be collated to complementary and matched
Fig. 1 (continued)
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datasets containing genomic and proteomic information. Similar
approaches can be readily tailored to study cells differentiated
from pluripotent stem cells or generated by other reprogramming
strategies.
3.1. Screening for optimal extracellular matrix protein conditions
Cell behaviour is heavily influenced by genetics and by the
surrounding environment [14,15]. In order to evaluate specific
differences on cell behaviour, we reasoned that diverse coating
concentrations on multiwell plates could be exploited. Thus, as a
prerequisite to build a scalable workflow suitable for the character-
isation of large panels of iPSCs, we first set out to identify an effec-
tive, robust and inexpensive substrate. We searched for an
extracellular matrix (ECM) protein or peptide that could be used
at different concentrations ranging from unfavourable to permis-
sive for cell attachment and cell spreading. Furthermore, we
searched for conditions to robustly detect a sufficient number of
single cells when plating the same number of iPSCs on a range of
diverse concentrations. In addition to these criteria, we also aimed
to keep the concentrations as low as possible to minimise the
presence of potential contaminants (e.g.: growth factors).
We tested 74 conditions (described in Section 2.2 and Table 1)
by seeding cells, imaging them live every hour for 24 h and fixing
and staining with DAPI, EdU and CellMask. Several conditions such
as fragments lacking RGD sites (e.g. from Agrin, Syndecan, Fibulin 4
and MAGP-1) yielded poor numbers of cells, similar to the BSA or
tissue culture plastic controls (Table 1, left insert). Others, such
as vitronectin allowed for attachment, spreading and survival
and yet cells were rarely found as single cells appearing mostly
in clumps (Table 1, right insert). Importantly, some of the
conditions tested allowed the attachment, spreading and survival
of single cells and additionally demonstrated a dose-dependent
response. These results suggest that varying concentrations of
one single substrate may lead to the establishment of assays tuning
cell response in terms of attachment, spreading, proliferation and
intercellular adhesion. For our screening experiments we used
two different vessel types: Sarstedt 96w (for the Orla plate) and
Greiner lClear (for the custom plate). Images acquired on the
Operetta appeared sharper for the Greiner lClear. Objective 4,
20 and 40 were unpractical or gave an unfavourable ratio of
cells on the borders versus cells in the field. We therefore used a
10 long working distance (WD) objective for 9 fields of view
per each well, excluding the peripheral fields and excitation 50%
and transmission 50% according to manufacturer’s instructions to
avoid photo-bleaching.
3.2. Assay development using a gradient of fibronectin concentrations
Among all promising substrates (Table 1, #65–74), we focused
on those that for practical reasons such as cost and robustness will
result suitable to a large number of iPSCs. Furthermore, these
might facilitate the scale up and industrial application of similar
strategies. Fibronectin is a large glycoprotein generally in the form
of an insoluble dimer. Several reports suggest an essential role for
fibronectin during vertebrate embryonic development [16] and tis-
sue regeneration [17]. In human iPSCs, several studies indicate that
fibronectin is a permissive substrate for the maintenance of
pluripotency [18–23]. In addition, its adsorption on tissue culture
plates has been shown to give rise to diverse structures with
diverse surface density affecting the number of focal adhesion con-
tacts [24]. In the human body, fibronectin exists in two forms: the
Fig. 1 (continued)
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plasma form circulates in the blood whereas cellular fibronectin is
physically associated to the cell surface [25]. Both cellular and
plasma fibronectin as well as other conditions presenting recombi-
nant peptides gave similar results in terms of total number of cells
attached and number of single cells. Fn1 and Fn25 conditions
yielded remarkable differences indicating an environment
conducive of low versus high cellular adhesion respectively,
whereas Fn10 appeared very similar to Fn25. We therefore sourced
Fig. 2. Assay development for cell density and time before fixation. (A) The panels show representative microphotographs for 3000 (Top) or 6000 (bottom) cells plated on
different fibronectin concentrations (Fn1, Fn5, Fn25). Note that the majority of cells when 6000 cells are plated appear in clumps. Blue, DAPI. Green, EdU. Red, CellMask. One
field of view per well is shown here. (B) Live image movies were derived and inspected of cells plated as 3000 cells on the three fibronectin conditions. Timepoints 1 h, 4 h,
12 h and 24 h after seeding are shown here. Adhering cells can be readily observed from 4 h onwards and spreading has occurred in most cells by 24 h.
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plasma fibronectin in conditions Fn1-Fn5-Fn25 to validate our
observations. To achieve statistical significance, these conditions
were each replicated three times on the same vessel in a ran-
domised pattern (Fig. 3A). We report here results from numerous
replicate experiments (n = 41).
Having chosen the extracellular matrix and a suitable range of
concentrations, we tested the initial cell density. A seeding density
below 3000 cells per well resulted in a suboptimal number of sin-
gle cells. On the other hand, when seeding 6000 cells on Fn25 we
observed a comparable number of single cells to those observed
when plating 3000 cells on Fn25. We also observed a high number
of clumps forming when plating 6000 cells on Fn1 (Fig. 2A). We
thus chose to plate 3000 cells per well as this seeding density
yielded an optimal number of single cells in all conditions tested.
To determine the most appropriate duration for our endpoint
assays we performed live imaging of cells plated in Fn1, Fn5 or
Fn25. The time chosen should be long enough for the cells to
adhere and be in line with the cell cycle described for human iPSCs
[26] to minimise complete cytokinesis. Ideally in this condition, the
total number of cells observed is deemed to depend more on cell
adherence and survival rather than on cell division. DNA
replication can then be validly assessed with a 30 min pulse of
EdU. Cells appeared to start adhering and spreading around 4 h
post-plating at all fibronectin concentrations. At 24 h, the vast
majority of the attached cells will have completed their spreading
with minor cell divisions observed (Fig. 2B). We therefore opted to
run the endpoint assays 24 h after plating.
3.3. Image analysis pipeline
Image acquisition parameters using Operetta have been
detailed in Sections 2 and 3. We here describe in details the image
analysis pipeline we have built using the Harmony 3.5.2 software
(summarised in the workflow diagram in Fig. 3B). Similar strate-
gies could be easily transferred to other, possibly open-source,
image analysis software platforms.
Fig. 3. Workflow diagram detailing image acquisition and analysis. (A) Layout of the 96-well plates for phenotype assays showing fibronectin concentration per column
(blue). Different experiments present randomised patterns (i.e. Fn1-Fn5-Fn25, Fn1-Fn25-Fn5, Fn5-Fn25-Fn1, Fn5-Fn1-Fn25, Fn25-Fn1-Fn5, Fn25-Fn5-Fn1). Step-by-step
experimental conditions for the assay set-up are detailed on the right. KOSR = KnockOut Serum Replacement, RT = room temperature, BSA = bovine serum albumin. (B) Image
analysis pipeline detailed in Section 3.3 is summarised here. Input images are segmented to identify nuclei and cytoplasm. Border objects and artefacts are discarded via
morphology and intensity assessment on nuclei and on cells. The modify population module is employed to identify clumps based on cell-to-cell proximity and capture the
number of cells in each clump as a context feature.
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We first used the Input Image module and proceeded to
minimise background by processing individual planes with a basic
flatfield correction and no quick tune. The find nuclei module seg-
ments nuclei using the DAPI channel and the M Method. A 18 lm
diameter was chosen with 0.40 splitting coefficient and 0.05 com-
mon threshold. These parameters allowed to efficiently segment an
output population named ‘Nuclei’ still carrying artefacts to be dis-
carded based on sizes and intensity of signals. Within the calculate
morphology properties module we used the standard methods on
the nuclei population and on the nucleus region to define area,
roundness and ratio width to length and output properties as
‘Nucleus’. We then used calculate intensity properties modules
for the Alexa488 channel (EdU), the brightfield and the DAPI out-
putting median intensities as properties for each object. Using
the select population module we then filtered by properties as fol-
lows: nucleus area between 60 lm2 and 600 lm2, EdU median
intensity below 10.000 and DAPI median intensity between 500
and 10.000 with brightfield over 0. This refined output population
was named ‘Nuclei 2’. We then used the find cytoplasm module on
channel CellMask Deepred on nuclei 2 choosing method A with
threshold 0.05. We select population again for ‘Nuclei 2’ removing
border objects (common filters) on cell region. The output popula-
tion was named ‘Cell unselected’. We then calculate morphology
properties for cell unselected on cell using standard method and
area, roundness and ratio width to length. The output properties
were named ‘Cell’. We then applied the select population module
using ‘Cell unselected’ and filter by property cells with cell area
below 6000 lm2. Thus, filters are applied discarding objects of
nucleus area below 60 lm2 and over 600 lm2, EdU median inten-
sity over 10,000 AU and DAPI median intensity under 500 or over
10,000 AU and cell area bigger than 6000 lm2 (the latter include
the vast majority of the few feeder cells present on the wells, see
Fig. 3B). From the modify population module we used the cluster
by distance method on the ‘cell’ population on cell region. Distance
was set as 0 and Area over 0 px and no fill holes. The output pop-
ulation was named ‘Clumps + Singles’. We then used the calculate
properties module on the ‘Clumps + Singles’ population choosing
the by related population method. Related population cell and
number of cell was considered as a property. The output properties
were defined ‘per clump’. We then applied the calculate properties
module to the cell population using by related population and
using the number of cell per clump leaving the output property
blank. In practical terms, a population is here modified to conglom-
erate ‘cells’ in a related ‘clump’ and to assess the number of ‘cells’
in each ‘clump’ and tag this back from the related population into
each ‘cell’ object having this value equal one for single cells. We
adapted this strategy from similar approaches [27]. We then used
the define results module exporting for the ‘cell’ population only
the following parameters for all cells producing single cell results
as selected. In total, for each ‘cell’ object, 9 phenotypic features
are defined: 6 morphology, 2 intensity and 1 context feature.
The morphology features selected are: nucleus area, nucleus
Fig. 4. Phenotypic features analysed and their aggregation. Cell-based measurements are aggregated in each well to well-based measurements. (A) Histogram of cell areas
with highlighted sample mean and standard deviation (in blue). (B) The EdU median intensity is aggregated using a Gaussian distribution fitting to the main peak of cells,
which is considered the EdU negative cells population. The area under the curve that is not explained by that main peak is considered the fraction of EdU positive cells (in
blue). (C) Distribution of clump sizes in well and the fit of a geometric distribution (in blue). Clump size refers to the number of cells in a clump. The inverse mean is the
parameter of that fit and is used to describe the tendency of the cells to form clumps. (D) Shows detail of all phenotypic features for single cells and all cells. l = mean
r = standard deviation.
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roundness, nucleus width to length ratio, cell area, cell roundness,
cell width to length ratio; The intensity features are: DAPI median
and EdU (488) median and the context feature captured is: Num-
ber of cell per clump sum (see Fig. 4).
3.4. Phenotypic features and their aggregation
For structured access, the output of the Harmony image analy-
sis pipeline was stored in a MySQL database along with experimen-
tal metadata including fibronectin concentration per well and
experiment number. Further processing, analysis and data visuali-
sation was performed within the statistical computing framework
R directly accessing the database.
The cell phenotypic features described above were suitably nor-
malised in value (log10 or square transformation) and aggregated
across the cells for each well by taking average and standard devi-
ation (Fig. 4A). The cell number was directly acquired from the
Harmony data. For EdU, median intensity raw values were grouped
and characterised on a well-based measure by the fraction of pos-
itive cells. We opted to quantify this as the area under the empir-
ical density not explained by a Gaussian main peak representing
EdU negative cells (see Fig. 4B). Tendency of cells to form clumps
was described for each well by two summary statistics: the frac-
tion of single cells and the inverse of the mean clump size. From
the distribution of clumps over clump sizes (Fig. 4C) we observed
exponentially less clumps of bigger sizes. The inverse of the mean
clump size as the defining parameter of that geometric distribution
proves therefore valid. Additionally, wells with fewer cells overall
tend to have more single cells in proportion, as the chance of cells
to come to contact is lower. Percentage of single cells was also used
as a measure of the ability of cells to form clumps.
We used the Number of cell per clump sum as a context feature
to maintain all objects in a common database interrogating sepa-
rately data from single cells versus from cells in clumps (Fig. 5).
Our assay demonstrated over 41 replicates a fraction of single cells
per well of 37% indicating the effectiveness of the chosen substrate
conditions in preserving a population of single cells (Fig. 5A).
Exploiting this strategy, we first asked whether cell–cell contact
affects phenotypic features. Cell area appeared different depending
on the context feature and showed a bimodal curve in single cells
(Fig. 5B, C, E) indicating the presence of a population of smaller sin-
gle cells likely not spreading. We postulated that cells that come in
contact with neighbouring cells may show distinct morphology
from single cells as they are constrained in shape by the presence
of their neighbours and cannot elongate as single cells. In fact, cell
roundness (Fig. 5C, D) and cell width to length (Fig. 5E, F) showed a
wider range for single cells than for cells in clump. These results
indicate that our assay is suited to capture differences in features
emerging upon intercellular adhesion. We next sought to observe
and quantify the effect on phenotypic features of different fibro-
nectin concentrations.
3.5. Diverse fibronectin concentrations trigger specific phenotypic
responses
We therefore asked whether changes in the concentration of
fibronectin affected the number of cells on the plate. We observed
as expected that the total number of cells was higher in Fn25,
intermediate in Fn5 and lower in Fn1 (Fig. 6A). We are seeding
Fig. 5. Phenotypic features vary in single cells and cells in clumps. Values of phenotypic features for single cells (blue) and cells in clumps (red) surrounded by at least one
neighbouring cell, examined across the fibronectin concentrations in a series of replicate experiments. (A) Shows the fraction of single cells obtained by the assay. Over one
third of cells (37%) appear as single cells. Min–Max range is shown. (B–F) morphological cell features for single cells and cells in clumps. Cell area, roundness and cell width to
length display a wider range in single cells versus cells in clumps. This is suggestive of constraint from neighbouring cells limiting the shape of cells in clumps. (D) Cell
roundness and (E) cell width to length are plotted versus cell area. These data are shown as examples of the validity of this method to capture features emerging upon cell–
cell contact.
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the same number of cells and the period of observation is relatively
short and consistent with the time required to attach and spread
before a cycle (see Section 3.2). Thus, we speculate that this differ-
ence in number of cells retrieved is more likely due to differences
in adherence and/or survival and less likely due to proliferation.
Accordingly, the fraction of EdU positive cells was comparable
(Fig. 6B). Also, we found an increased tendency to form clumps in
Fn25 in terms of inverse of mean clump size (Fig. 6C). We cannot
rule out that this may be an indirect effect of fibronectin through
cell number or cell migration. In agreement with visual inspection,
both cell and nuclear morphology varied substantially in these
diverse conditions. We found wider ranges in cell area on Fn25
whereas cells appeared more round on Fn1 (Fig. 6C). Similar obser-
vations were made for width to length (not shown). Density plots
of nuclear area (Fig. 6D), roundness (Fig. 6E) and width to length
(Fig. 6E) also presented differences in these features at a popula-
tion level.
We finally asked whether the developed assay and the cell phe-
notypic features obtained were sufficient to separate in a high
dimensional features space cells in different fibronectin concentra-
tions. We thus performed principal component analysis (PCA,
Fig. 7A). The defined features affected variably the two compo-
nents (Fig. 7B) which together explained a percentage of variance
of approximately two thirds (Fig. 7C). An elliptic area representing
68% of the sample space showed non-overlapping Fn1 and Fn25
conditions whereas Fn5 appeared intermediate. Altogether these
results demonstrate that the high content platform we developed
is suited to quantify phenotypic feature changes in human iPSCs
that depend on cell–cell contact and biological responses triggered
by different substrate conditions.
Fig. 6. Fibronectin conditions affect several phenotypic features. Phenotypic features were interrogated in a series of replicate experiments for each of three fibronectin
concentrations in all cells (Fn1; green, Fn5; grey, Fn25, red). (A) Number of cells per well. Min–Max range is shown. (B) Fraction of EdU positive cells over the three fibronectin
concentrations. Min–Max range is shown. (C) Inverse mean clump size, an indicator of the propensity of cells to clump. (D) Cell roundness plotted over cell area. Note that
cells in higher concentration of fibronectin present a wider range of values. (E–G) Density plots for nucleus area, nucleus roundness and nucleus width to length. The y axe
shows the relative fraction of cells. Min–Max range is shown. In all graphs: green, Fn1; grey, Fn5; Orange, Fn25.
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3.6. Potential modifications to the current pipeline and conclusions
We deliberately chose a simple cytochemistry based read-out
using only dyes to set up our workflow. Nonetheless, the content
of this assay read-out can be easily increased using antibodies
and other reporters. We have observed that the binding to fibro-
nectin is partially blocked by disturbance with an anti-b1 integrin
antibody indicating a specific effect of the substrate on the cell sur-
face iPSCs. Blocking antibodies, inhibitors as well as other different
environments could be used in similar approaches to challenge cell
responses. The methods were developed on feeder-dependent iPSC
lines and also successfully tested on feeder free cells. One possible
confounding factor is the presence of sparse feeder cells among the
iPSCs. Reassuringly, and as a negative control, dissociation with
dispase and collagenase did not dissociate a cell culture composed
of feeder cells only (Data not shown). The rare contaminating fee-
der cells are in the vast majority discarded based on their size.
Changes in the pipeline such as the introduction of a machine
learning classifiers were therefore deemed not necessary for this
level of contamination but may be considered in the future for sim-
ilar studies. It is also possible to exclude clumps over a certain size
to contain artefact from suboptimal seeding although this was also
deemed not necessary with the current experimental conditions.
To enrich the panel of morphological features analysed to train
classifiers, an extensive array of other morphological features
could also be derived in combination with the described morphol-
ogy features. Specific phenotypic traits can be examined further,
for example improving the adherence would result in larger pro-
duction of cells in a faster, more efficient and cost-effective man-
ner. Furthermore, controlling the distribution of single cells
versus clump may help the development of methods for homoge-
neous delivery to the cells of factors and a more stringent control
of differentiation protocols. In conclusion, the characterisation of
large panels of iPSCs is an important and challenging task. The
method we describe here can be applied to test large panel of iPSCs
to benchmark and characterise their phenotype and can readily be
tailored to the acquisition of other parameters and the analysis of
differentiated cell types.
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Fig. 7. Fibronectin conditions mediate distinct phenotypic responses. (A) Principal component analysis is performed on the described phenotypic features in a series of
replicate experiments. Green, Fn1; Grey Fn5; Orange Fn25. The ellipses represent the higher dimensional space defined by 68% of samples. (B) Directionality of the
contributions of each phenotypic features to the first two components. (C) Percentage of variance explained by each component. Phenotypic features extracted from cells
exposed to different fibronectin concentrations segregate in a high dimensional space.
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